title: Are reduced tacrolimus dosages needed in the early postoperative period following living donor liver transplantation in adults?
authors.affiliation: Department of Hepato-Biliary and Liver Transplantation Surgery, 2K12 1C Suite 307, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium.
authors.forename: R
authors.initials: R
authors.lastname: Troisi
authors.forename: G
authors.initials: G
authors.lastname: Militerno
authors.forename: E
authors.initials: E
authors.lastname: Hoste
authors.forename: J
authors.initials: J
authors.lastname: Decruyenaere
authors.forename: K
authors.initials: K
authors.lastname: Colpaert
authors.forename: K
authors.initials: K
authors.lastname: Monsieurs
authors.forename: I
authors.initials: I
authors.lastname: Colle
authors.forename: H
authors.initials: H
authors.lastname: Van Vlierberghe
authors.forename: B
authors.initials: B
authors.lastname: de Hemptinne
mesh_terms: D000328:Adult; D001835:Body Weight; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D019520:Living Donors; D009929:Organ Size; D011184:Postoperative Period; D016559:Tacrolimus / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus